CS logo
small CS logo
Meharry Medical College

Nashville, Tennessee, United States
Medical school in Nashville, Tennessee
1005 Dr DB Todd Jr Blvd, Nashville, TN 37208

About Meharry Medical College


Meharry Medical College is a historically black medical school affiliated with the United Methodist Church and located in Nashville, Tennessee. Founded in 1876 as the Medical Department of Central Tennessee College, it was the first medical school for African Americans in the South.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Meharry Medical College


During the past decade, Meharry Medical College conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 55 clinical trials were completed, i.e. on average, 141% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 22 clinical trials were completed. i.e. 169.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years889977111166442211666688667744779922Started TrialsCompleted Trails2015201620172018201920202021202220230510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1999-09-01
Completed
2,000
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
1996-09-01
Completed
1,292
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
1998-10-01
Completed
164
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
1997-06-01
Completed
1,750
A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
2002-06-01
Completed
560
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
2000-01-01
2010-03-01
Terminated
589
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer
2000-04-04
2009-02-10
Completed
774

Rows per page:

1–100 of 141

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Meharry Medical College" #1 sponsor was "National Cancer Institute (NCI)" with 31 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Vanderbilt-Ingram Cancer Center" with 13 trials sponsored and "Meharry Medical College" with 13 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Meharry Medical College" #1 collaborator was "National Cancer Institute (NCI)" with 69 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "Canadian Cancer Trials Group" with 5 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 68 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 31National CancerInstitute (NCI): 31SWOG Cancer ResearchNetwork: 19SWOG Cancer ResearchNetwork: 19Alliance for ClinicalTrials in Oncology: 13Alliance for ClinicalTrials in Oncology: 13Vanderbilt-IngramCancer Center: 13Vanderbilt-IngramCancer Center: 13Meharry Medical College: 12Meharry Medical College: 12ECOG-ACRIN CancerResearch Group: 6ECOG-ACRIN CancerResearch Group: 6National Institute ofAllergy and InfectiousDiseases (NIAID): 5National Institute ofAllergy and InfectiousDiseases (NIAID): 5Duke University: 3Duke University: 3Gynecologic Oncology Group: 3Gynecologic Oncology Group: 3Vanderbilt UniversityMedical Center: 3Vanderbilt UniversityMedical Center: 3

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 69National CancerInstitute (NCI): 69NCIC Clinical Trials Group: 9NCIC Clinical Trials Group: 9SWOG Cancer ResearchNetwork: 7SWOG Cancer ResearchNetwork: 7Cancer and LeukemiaGroup B: 6Cancer and LeukemiaGroup B: 6Canadian Cancer Trials Group: 5Canadian Cancer Trials Group: 5Eastern CooperativeOncology Group: 5Eastern CooperativeOncology Group: 5NRG Oncology: 5NRG Oncology: 5North Central CancerTreatment Group: 5North Central CancerTreatment Group: 5National Institute onAging (NIA): 4National Institute onAging (NIA): 4Bayer: 3Bayer: 3

Clinical Trials Conditions at Meharry Medical College


According to Clinical.Site data, the most researched conditions in "Meharry Medical College" are "Breast Cancer" (16 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Lung Cancer" (8 trials), "Stage IIIA Breast Cancer" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Meharry Medical College" in a lesser frequency.

Clinical Trials Intervention Types at Meharry Medical College


Most popular intervention types in "Meharry Medical College" are "Drug" (97 trials), "Other" (69 trials), "Biological" (35 trials), "Procedure" (24 trials) and "Behavioral" (11 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (38 trials), "Quality-of-Life Assessment" (20 trials), "Placebo" (14 trials), "Carboplatin" (12 trials) and "Paclitaxel" (12 trials). Other intervention names were less common.

Clinical Trials Genders at Meharry Medical College


The vast majority of trials in "Meharry Medical College" are 98 trials for "All" genders, 37 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Meharry Medical College


Currently, there are 53 active trials in "Meharry Medical College". 1 are not yet recruiting, 12 are recruiting, 39 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in Meharry Medical College, undefined suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Meharry Medical College, 3 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 22 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 70Phase 3: 70Phase 2: 37Phase 2: 37Not Applicable: 22Not Applicable: 22Phase 4: 4Phase 4: 4Phase 1: 3Phase 1: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 68Completed: 68Active, not recruiting: 39Active, not recruiting: 39Recruiting: 12Recruiting: 12Terminated: 12Terminated: 12Unknown status: 7Unknown status: 7Enrolling by invitation: 1Enrolling by invitation: 1Not yet recruiting: 1Not yet recruiting: 1Withdrawn: 1Withdrawn: 1